Logo
  • Investing
  • Stock
  • Economy
  • Latest News
Skip to content
Stock
  • Economy
  • Investing
  • Latest News
  • Stock
#
Categories Stock

Here’s why I’d avoid the JEPI ETF and buy the low-yielding VOO instead

September 16, 2025

The JPMorgan Equity Premium ETF (JEPI) has jumped to a record high this year, helped by the strong performance of American stocks.

#
Categories Stock

Here’s why the Gemini stock may crash soon after the IPO

September 16, 2025

Gemini stock price had a highly volatile first day as a publicly traded company. It initially popped to $45 after the much-anticipated

#
Categories Stock

Here’s why the Opendoor stock short-squeeze is gaining steam

September 16, 2025

Opendoor stock price has gone parabolic this year, adding over $5.8 billion to its market capitalization. OPEN jumped to a high of

#
Categories Stock

Top crypto price predictions: Avantis (AVNT), Zora, Zebec Network (ZBCN)

September 16, 2025

The crypto market started the week being under pressure as investors waited for the upcoming Federal Reserve interest rate decision, which will

#
Categories Stock

The NYT stock was trading at $60, up by 32% from its lowest level this year

September 16, 2025

The New York Times stock price is doing well this year and is hovering near its all-time high, helped by the surging

#
Categories Stock

Bitcoin price prediction: will BTC rise or fall after Fed rate cuts

September 16, 2025

Bitcoin price has held steady above the important support level at $115,000 as traders waited for the closely-watched Federal Reserve interest rate

#
Categories Stock

USD/NGN: Here’s why the Nigerian naira currency is soaring

September 16, 2025

The Nigerian naira is firing on all cylinders, mirroring the performance of the Kenyan shilling. The USD/NGN exchange rate plunged to a

#
Categories Stock

Lloyds share price forecast ahead of BoE interest rate decision

September 16, 2025

The Lloyds share price has rebounded in the past few days, moving from a low of 77.40p earlier this month to 84.22p

Posts navigation

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!



    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Trending News

    • Recent Posts
    #

    S&P 500, Dow Jones, Nasdaq 100 crash explained: will they rebound?

    The S&P 500, Dow Jones, and Nasdaq 100 indices and their exchange-traded funds (ETF) future...

    #

    Crypto market price predictions: Zcash, Shiba Inu, Morpho

    The crypto market crawled back today, October 18, as traders bought the recent dip and as hopes of...

    #

    Top crypto market news to watch this week

    The crypto market was highly volatile last week as investors reacted to the recent liquidation that...

    #

    Slotland Celebrates 27 Years of iGaming Innovation with New Games and Birthday Promotions

    The post Slotland Celebrates 27 Years of iGaming Innovation with New Games and Birthday Promotions...

    #

    Best Crypto To Buy Now: Why MUTM Stands Out Over XRP

    The post Best Crypto To Buy Now: Why MUTM Stands Out Over XRP appeared first on Coinpedia Fintech...

    #

    3 High-Potential Altcoins that Could Retire You This Year – Find Out Experts’ Top Picks

    The post 3 High-Potential Altcoins that Could Retire You This Year – Find Out Experts’ Top...

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: Biotech-savvy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 Biotech-savvy.com